PDL BioPharma Inc (NASDAQ:PDLI)

2.90
Delayed Data
As of Apr 20
 0.00 / 0.00%
Today’s Change
2.01
Today|||52-Week Range
3.55
+5.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line7.2M60.4M20.7M22.3M
 
 
 
 
 
Depreciation6.0M6.1M6.3M6.3M
 
 
 
 
 
Total Other Cash Flow-7.9M-78.3M-34.0M-33.9M
 
 
 
 
 
Funds From Operations20.6M2.2M-7.3M4.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-25.1M-13.6M-5.1M23.7M
 
 
 
 
 
Net Cash Flow - Operating Activities45.8M15.8M-2.1M-18.8M
 
 
 
 
 
 
InvestingIncrease In Investments-16.0M-3.9M-4.8M1.4M
 
 
 
 
 
Decrease In Investments16.0M13.0M83.9M2.1M
 
 
 
 
 
Capital Expenditures-534.0K-171.0K-455.0K-137.0K
 
 
 
 
 
Net Assets From Acquisitions 0.000.00-2.2M0.00
 
 
Other Investing - Sources129.6M34.8M171.2M32.9M
 
 
 
 
 
Net Cash Flow Investing129.1M43.8M247.6M36.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings------0.00--
Long Term Debt Reduction----------
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-7.6M-22.4M0.000.00
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-21.0K0.000.00-201.0K
 
 
 
Other Sources - Financing0.00--------
Other Uses - Financing0.002.2M84.8M0.00
 
 
 
Net Cash Flow - Financing-7.7M-24.5M-84.8M-201.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash167.2M35.1M160.7M17.2M